BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 17452521)

  • 21. E protein transcription factors are required for the development of CD4(+) lineage T cells.
    Jones-Mason ME; Zhao X; Kappes D; Lasorella A; Iavarone A; Zhuang Y
    Immunity; 2012 Mar; 36(3):348-61. PubMed ID: 22425249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitors of DNA binding proteins restrict T cell potential by repressing Notch1 expression in Flt3-negative common lymphoid progenitors.
    Pereira de Sousa A; Berthault C; Granato A; Dias S; Ramond C; Kee BL; Cumano A; Vieira P
    J Immunol; 2012 Oct; 189(8):3822-30. PubMed ID: 22972921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Id2
    Xu W; Cherrier DE; Chea S; Vosshenrich C; Serafini N; Petit M; Liu P; Golub R; Di Santo JP
    Immunity; 2019 Apr; 50(4):1054-1068.e3. PubMed ID: 30926235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential requirement for Nfil3 during NK cell development.
    Seillet C; Huntington ND; Gangatirkar P; Axelsson E; Minnich M; Brady HJ; Busslinger M; Smyth MJ; Belz GT; Carotta S
    J Immunol; 2014 Mar; 192(6):2667-76. PubMed ID: 24532575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammalian target of rapamycin regulates the growth of mammary epithelial cells through the inhibitor of deoxyribonucleic acid binding Id1 and their functional differentiation through Id2.
    Jankiewicz M; Groner B; Desrivières S
    Mol Endocrinol; 2006 Oct; 20(10):2369-81. PubMed ID: 16772532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of inhibitor of binding or differentiation 2 in the development and differentiation of immune cells.
    Wu H; Shao Q
    Immunobiology; 2019 Jan; 224(1):142-146. PubMed ID: 30340915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential Expression of the Transcription Factor GATA3 Specifies Lineage and Functions of Innate Lymphoid Cells.
    Zhong C; Zheng M; Cui K; Martins AJ; Hu G; Li D; Tessarollo L; Kozlov S; Keller JR; Tsang JS; Zhao K; Zhu J
    Immunity; 2020 Jan; 52(1):83-95.e4. PubMed ID: 31882362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased ID2 levels in adult precursor B cells as compared with children is associated with impaired Ig locus contraction and decreased bone marrow output.
    Jensen K; Rother MB; Brusletto BS; Olstad OK; Dalsbotten Aass HC; van Zelm MC; Kierulf P; Gautvik KM
    J Immunol; 2013 Aug; 191(3):1210-9. PubMed ID: 23825313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Id2 negatively regulates B cell differentiation in the spleen.
    Becker-Herman S; Lantner F; Shachar I
    J Immunol; 2002 Jun; 168(11):5507-13. PubMed ID: 12023345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A committed precursor to innate lymphoid cells.
    Constantinides MG; McDonald BD; Verhoef PA; Bendelac A
    Nature; 2014 Apr; 508(7496):397-401. PubMed ID: 24509713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ebf1-mediated down-regulation of Id2 and Id3 is essential for specification of the B cell lineage.
    Thal MA; Carvalho TL; He T; Kim HG; Gao H; Hagman J; Klug CA
    Proc Natl Acad Sci U S A; 2009 Jan; 106(2):552-7. PubMed ID: 19122139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The divergence between T cell and innate lymphoid cell fates controlled by E and Id proteins.
    Pankow A; Sun XH
    Front Immunol; 2022; 13():960444. PubMed ID: 36032069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E2A promotes the survival of precursor and mature B lymphocytes.
    Lazorchak AS; Wojciechowski J; Dai M; Zhuang Y
    J Immunol; 2006 Aug; 177(4):2495-504. PubMed ID: 16888011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Id3 and Id2 act as a dual safety mechanism in regulating the development and population size of innate-like γδ T cells.
    Zhang B; Lin YY; Dai M; Zhuang Y
    J Immunol; 2014 Feb; 192(3):1055-1063. PubMed ID: 24379125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polycomb repressor complex 2 regulates HOXA9 and HOXA10, activating ID2 in NK/T-cell lines.
    Nagel S; Venturini L; Marquez VE; Meyer C; Kaufmann M; Scherr M; MacLeod RA; Drexler HG
    Mol Cancer; 2010 Jun; 9():151. PubMed ID: 20565746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow.
    Daussy C; Faure F; Mayol K; Viel S; Gasteiger G; Charrier E; Bienvenu J; Henry T; Debien E; Hasan UA; Marvel J; Yoh K; Takahashi S; Prinz I; de Bernard S; Buffat L; Walzer T
    J Exp Med; 2014 Mar; 211(3):563-77. PubMed ID: 24516120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diverse roles of inhibitor of differentiation 2 in adaptive immunity.
    Rankin L; Belz GT
    Clin Dev Immunol; 2011; 2011():281569. PubMed ID: 21437223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the earliest NK-cell precursor in the mouse BM.
    Carotta S; Pang SH; Nutt SL; Belz GT
    Blood; 2011 May; 117(20):5449-52. PubMed ID: 21422472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The transcription factors E2A and HEB act in concert to induce the expression of FOXO1 in the common lymphoid progenitor.
    Welinder E; Mansson R; Mercer EM; Bryder D; Sigvardsson M; Murre C
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17402-7. PubMed ID: 21972416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow versus thymic pathways of natural killer cell development.
    Di Santo JP; Vosshenrich CA
    Immunol Rev; 2006 Dec; 214():35-46. PubMed ID: 17100874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.